This diagnostic test detects the risk level of oral precancerous lesions and oral cancers by measuring the methylation level of ZNF582 and PAX1. It is an adjunctive test that assists physicians with VOE, and which helps to determine a follow-up decision as to whether to pursue a histopathological examination. Here, PAX1 is linked to lip and oral cavity carcinoma.